English
简体中文
Total: £ 56.28
Published Date: 2025-06-12 | Pages: 152 | Tables: 157 | Medical Care
In 2024, the global market size of In-Vitro Diagnostics was estimated to be worth US$ 70210 million and is forecast to reach approximately US$ 94510 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.
The concentration of the market is relatively high, and the first 16 companies include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, JNJ, Sysmex, KHB, DaAn Gene, Leadman, BioSino, BSBE and Maccura, they occupied more than 66% of whole market. US dominates the market which occupied 43% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 7% of the whole market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for In-Vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Vitro Diagnostics.
The In-Vitro Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In-Vitro Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-Vitro Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Roche
Siemens
Abbott
Danaher
Thermo Fisher
BioMerieux
Bio-Rad
BD
JNJ
Sysmex
KHB
DaAn Gene
Leadman
BioSino
BSBE
Maccura
Segment by Type
Tissue Diagnostics
Professional Diagnostic
Molecular Diagnostic
Diabetes Monitoring
Other
Segment by Application
Diabetes
Infectious Diseases
Oncology
Cardiology
HIV
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of In-Vitro Diagnostics in global and regional level.
Chapter 3: Detailed analysis of In-Vitro Diagnostics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In-Vitro Diagnostics revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 In-Vitro Diagnostics Product Introduction
1.2 Market by Type
1.2.1 Global In-Vitro Diagnostics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Tissue Diagnostics
1.2.3 Professional Diagnostic
1.2.4 Molecular Diagnostic
1.2.5 Diabetes Monitoring
1.2.6 Other
1.3 Market by Application
1.3.1 Global In-Vitro Diagnostics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Diabetes
1.3.3 Infectious Diseases
1.3.4 Oncology
1.3.5 Cardiology
1.3.6 HIV
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global In-Vitro Diagnostics Market Size Estimates and Forecasts
2.2 In-Vitro Diagnostics Market Size by Region: 2024 Versus 2031
2.2.1 Global In-Vitro Diagnostics Revenue by Region: 2020-2025
2.2.2 Global In-Vitro Diagnostics Revenue Forecast by Region (2026-2031)
2.2.3 Global In-Vitro Diagnostics Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global In-Vitro Diagnostics Revenue by Type (2020-2031)
3.1.2 Global In-Vitro Diagnostics Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global In-Vitro Diagnostics Revenue by Application (2020-2031)
3.2.2 Global In-Vitro Diagnostics Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Tissue Diagnostics of In-Vitro Diagnostics Revenue Market Share by Application
3.3.2 Professional Diagnostic of In-Vitro Diagnostics Revenue Market Share by Application
3.3.3 Molecular Diagnostic of In-Vitro Diagnostics Revenue Market Share by Application
3.3.4 Diabetes Monitoring of In-Vitro Diagnostics Revenue Market Share by Application
3.3.5 Other of In-Vitro Diagnostics Revenue Market Share by Application
4 Global In-Vitro Diagnostics by Company
4.1 Global In-Vitro Diagnostics Revenue by Company (2020-2025)
4.2 Global In-Vitro Diagnostics Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key In-Vitro Diagnostics Companies around the World: Ranking by Revenue
4.3.2 Global In-Vitro Diagnostics Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global In-Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global In-Vitro Diagnostics Companies Headquarters & Product Type
4.4.1 Global In-Vitro Diagnostics Companies Headquarters
4.4.2 Date of International Companies Enter into In-Vitro Diagnostics Market
4.4.3 Global In-Vitro Diagnostics Companies Product & Service
4.4.4 Tissue Diagnostics Revenue Market Share of In-Vitro Diagnostics by Company
4.4.5 Professional Diagnostic Revenue Market Share of In-Vitro Diagnostics by Company
4.4.6 Molecular Diagnostic Revenue Market Share of In-Vitro Diagnostics by Company
4.4.7 Diabetes Monitoring Revenue Market Share of In-Vitro Diagnostics by Company
4.4.8 Other Revenue Market Share of In-Vitro Diagnostics by Company
4.5 Global In-Vitro Diagnostics Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Roche
5.1.1 Roche Corporation Information
5.1.2 Roche Description, Business Overview
5.1.3 Roche In-Vitro Diagnostics Products Offered
5.1.4 Roche In-Vitro Diagnostics Revenue and Gross Margin (2020-2025)
5.1.5 Roche In-Vitro Diagnostics Revenue by Product in 2024
5.1.6 Roche In-Vitro Diagnostics Revenue by Application in 2024
5.1.7 Roche In-Vitro Diagnostics Revenue by Geographic Area in 2024
5.1.8 Roche Recent Developments
5.2 Siemens
5.2.1 Siemens Corporation Information
5.2.2 Siemens Description, Business Overview
5.2.3 Siemens In-Vitro Diagnostics Products Offered
5.2.4 Siemens In-Vitro Diagnostics Revenue and Gross Margin (2020-2025)
5.2.5 Siemens In-Vitro Diagnostics Revenue by Product in 2024
5.2.6 Siemens In-Vitro Diagnostics Revenue by Application in 2024
5.2.7 Siemens In-Vitro Diagnostics Revenue by Geographic Area in 2024
5.2.8 Siemens Recent Developments
5.3 Abbott
5.3.1 Abbott Corporation Information
5.3.2 Abbott Description, Business Overview
5.3.3 Abbott In-Vitro Diagnostics Products Offered
5.3.4 Abbott In-Vitro Diagnostics Revenue and Gross Margin (2020-2025)
5.3.5 Abbott In-Vitro Diagnostics Revenue by Product in 2024
5.3.6 Abbott In-Vitro Diagnostics Revenue by Application in 2024
5.3.7 Abbott In-Vitro Diagnostics Revenue by Geographic Area in 2024
5.3.8 Abbott Recent Developments
5.4 Danaher
5.4.1 Danaher Corporation Information
5.4.2 Danaher Description, Business Overview
5.4.3 Danaher In-Vitro Diagnostics Products Offered
5.4.4 Danaher In-Vitro Diagnostics Revenue and Gross Margin (2020-2025)
5.4.5 Danaher In-Vitro Diagnostics Revenue by Product in 2024
5.4.6 Danaher In-Vitro Diagnostics Revenue by Application in 2024
5.4.7 Danaher In-Vitro Diagnostics Revenue by Geographic Area in 2024
5.4.8 Danaher Recent Developments
5.5 Thermo Fisher
5.5.1 Thermo Fisher Corporation Information
5.5.2 Thermo Fisher Description, Business Overview
5.5.3 Thermo Fisher In-Vitro Diagnostics Products Offered
5.5.4 Thermo Fisher In-Vitro Diagnostics Revenue and Gross Margin (2020-2025)
5.5.5 Thermo Fisher In-Vitro Diagnostics Revenue by Product in 2024
5.5.6 Thermo Fisher In-Vitro Diagnostics Revenue by Application in 2024
5.5.7 Thermo Fisher In-Vitro Diagnostics Revenue by Geographic Area in 2024
5.5.8 Thermo Fisher Recent Developments
5.6 BioMerieux
5.6.1 BioMerieux Corporation Information
5.6.2 BioMerieux Description, Business Overview
5.6.3 BioMerieux In-Vitro Diagnostics Products Offered
5.6.4 BioMerieux In-Vitro Diagnostics Revenue and Gross Margin (2020-2025)
5.6.5 BioMerieux In-Vitro Diagnostics Revenue by Product in 2024
5.6.6 BioMerieux In-Vitro Diagnostics Revenue by Application in 2024
5.6.7 BioMerieux In-Vitro Diagnostics Revenue by Geographic Area in 2024
5.6.8 BioMerieux Recent Developments
5.7 Bio-Rad
5.7.1 Bio-Rad Corporation Information
5.7.2 Bio-Rad Description, Business Overview
5.7.3 Bio-Rad In-Vitro Diagnostics Products Offered
5.7.4 Bio-Rad In-Vitro Diagnostics Revenue and Gross Margin (2020-2025)
5.7.5 Bio-Rad In-Vitro Diagnostics Revenue by Product in 2024
5.7.6 Bio-Rad In-Vitro Diagnostics Revenue by Application in 2024
5.7.7 Bio-Rad In-Vitro Diagnostics Revenue by Geographic Area in 2024
5.7.8 Bio-Rad Recent Developments
5.8 BD
5.8.1 BD Corporation Information
5.8.2 BD Description, Business Overview
5.8.3 BD In-Vitro Diagnostics Products Offered
5.8.4 BD In-Vitro Diagnostics Revenue and Gross Margin (2020-2025)
5.8.5 BD In-Vitro Diagnostics Revenue by Product in 2024
5.8.6 BD In-Vitro Diagnostics Revenue by Application in 2024
5.8.7 BD In-Vitro Diagnostics Revenue by Geographic Area in 2024
5.8.8 BD Recent Developments
5.9 JNJ
5.9.1 JNJ Corporation Information
5.9.2 JNJ Description, Business Overview
5.9.3 JNJ In-Vitro Diagnostics Products Offered
5.9.4 JNJ In-Vitro Diagnostics Revenue and Gross Margin (2020-2025)
5.9.5 JNJ In-Vitro Diagnostics Revenue by Product in 2024
5.9.6 JNJ In-Vitro Diagnostics Revenue by Application in 2024
5.9.7 JNJ In-Vitro Diagnostics Revenue by Geographic Area in 2024
5.9.8 JNJ Recent Developments
5.10 Sysmex
5.10.1 Sysmex Corporation Information
5.10.2 Sysmex Description, Business Overview
5.10.3 Sysmex In-Vitro Diagnostics Products Offered
5.10.4 Sysmex In-Vitro Diagnostics Revenue and Gross Margin (2020-2025)
5.10.5 Sysmex In-Vitro Diagnostics Revenue by Product in 2024
5.10.6 Sysmex In-Vitro Diagnostics Revenue by Application in 2024
5.10.7 Sysmex In-Vitro Diagnostics Revenue by Geographic Area in 2024
5.10.8 Sysmex Recent Developments
5.11 KHB
5.11.1 KHB Corporation Information
5.11.2 KHB Description, Business Overview
5.11.3 KHB In-Vitro Diagnostics Products Offered
5.11.4 KHB In-Vitro Diagnostics Revenue and Gross Margin (2020-2025)
5.11.5 KHB In-Vitro Diagnostics Revenue by Product in 2024
5.11.6 KHB In-Vitro Diagnostics Revenue by Application in 2024
5.11.7 KHB In-Vitro Diagnostics Revenue by Geographic Area in 2024
5.11.8 KHB Recent Developments
5.12 DaAn Gene
5.12.1 DaAn Gene Corporation Information
5.12.2 DaAn Gene Description, Business Overview
5.12.3 DaAn Gene In-Vitro Diagnostics Products Offered
5.12.4 DaAn Gene In-Vitro Diagnostics Revenue and Gross Margin (2020-2025)
5.12.5 DaAn Gene In-Vitro Diagnostics Revenue by Product in 2024
5.12.6 DaAn Gene In-Vitro Diagnostics Revenue by Application in 2024
5.12.7 DaAn Gene In-Vitro Diagnostics Revenue by Geographic Area in 2024
5.12.8 DaAn Gene Recent Developments
5.13 Leadman
5.13.1 Leadman Corporation Information
5.13.2 Leadman Description, Business Overview
5.13.3 Leadman In-Vitro Diagnostics Products Offered
5.13.4 Leadman In-Vitro Diagnostics Revenue and Gross Margin (2020-2025)
5.13.5 Leadman In-Vitro Diagnostics Revenue by Product in 2024
5.13.6 Leadman In-Vitro Diagnostics Revenue by Application in 2024
5.13.7 Leadman In-Vitro Diagnostics Revenue by Geographic Area in 2024
5.13.8 Leadman Recent Developments
5.14 BioSino
5.14.1 BioSino Corporation Information
5.14.2 BioSino Description, Business Overview
5.14.3 BioSino In-Vitro Diagnostics Products Offered
5.14.4 BioSino In-Vitro Diagnostics Revenue and Gross Margin (2020-2025)
5.14.5 BioSino In-Vitro Diagnostics Revenue by Product in 2024
5.14.6 BioSino In-Vitro Diagnostics Revenue by Application in 2024
5.14.7 BioSino In-Vitro Diagnostics Revenue by Geographic Area in 2024
5.14.8 BioSino Recent Developments
5.15 BSBE
5.15.1 BSBE Corporation Information
5.15.2 BSBE Description, Business Overview
5.15.3 BSBE In-Vitro Diagnostics Products Offered
5.15.4 BSBE In-Vitro Diagnostics Revenue and Gross Margin (2020-2025)
5.15.5 BSBE In-Vitro Diagnostics Revenue by Product in 2024
5.15.6 BSBE In-Vitro Diagnostics Revenue by Application in 2024
5.15.7 BSBE In-Vitro Diagnostics Revenue by Geographic Area in 2024
5.15.8 BSBE Recent Developments
5.16 Maccura
5.16.1 Maccura Corporation Information
5.16.2 Maccura Description, Business Overview
5.16.3 Maccura In-Vitro Diagnostics Products Offered
5.16.4 Maccura In-Vitro Diagnostics Revenue and Gross Margin (2020-2025)
5.16.5 Maccura In-Vitro Diagnostics Revenue by Product in 2024
5.16.6 Maccura In-Vitro Diagnostics Revenue by Application in 2024
5.16.7 Maccura In-Vitro Diagnostics Revenue by Geographic Area in 2024
5.16.8 Maccura Recent Developments
6 North America
6.1 North America In-Vitro Diagnostics Market Size YoY Growth 2020-2031
6.2 North America In-Vitro Diagnostics Market Facts & Figures by Country (2020-2031)
6.3 North America In-Vitro Diagnostics Revenue by Type (2020-2025)
6.4 North America In-Vitro Diagnostics Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific In-Vitro Diagnostics Market Size YoY Growth 2020-2031
7.2 Asia-Pacific In-Vitro Diagnostics Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific In-Vitro Diagnostics Revenue by Type (2020-2025)
7.4 Asia-Pacific In-Vitro Diagnostics Revenue by Application (2020-2025)
8 Europe
8.1 Europe In-Vitro Diagnostics Market Size YoY Growth 2020-2031
8.2 Europe In-Vitro Diagnostics Market Facts & Figures by Country (2020-2031)
8.3 Europe In-Vitro Diagnostics Revenue by Type (2020-2025)
8.4 Europe In-Vitro Diagnostics Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America In-Vitro Diagnostics Market Size YoY Growth 2020-2031
9.2 Latin America In-Vitro Diagnostics Market Facts & Figures by Country (2020-2031)
9.3 Latin America In-Vitro Diagnostics Revenue by Type (2020-2025)
9.4 Latin America In-Vitro Diagnostics Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America In-Vitro Diagnostics Market Size YoY Growth 2020-2031
10.2 Middle East and Africa In-Vitro Diagnostics Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa In-Vitro Diagnostics Revenue by Type (2020-2025)
10.4 Middle East and Africa In-Vitro Diagnostics Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 In-Vitro Diagnostics Supply Chain Analysis
11.2 In-Vitro Diagnostics Key Raw Materials and Upstream Suppliers
11.3 In-Vitro Diagnostics Clients Analysis
11.4 In-Vitro Diagnostics Sales Channel and Sales Model Analysis
11.4.1 In-Vitro Diagnostics Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 In-Vitro Diagnostics Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 In-Vitro Diagnostics Distributors
12 In-Vitro Diagnostics Market Dynamics
12.1 In-Vitro Diagnostics Industry Trends
12.2 In-Vitro Diagnostics Market Drivers
12.3 In-Vitro Diagnostics Market Challenges
12.4 In-Vitro Diagnostics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global In-Vitro Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global In-Vitro Diagnostics Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global In-Vitro Diagnostics Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global In-Vitro Diagnostics Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global In-Vitro Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global In-Vitro Diagnostics Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global In-Vitro Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global In-Vitro Diagnostics Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. In-Vitro Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 11. In-Vitro Diagnostics Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top In-Vitro Diagnostics Players by Revenue (US$ Million) in 2024
Table 13. Global In-Vitro Diagnostics Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global In-Vitro Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Diagnostics as of 2024)
Table 15. Global In-Vitro Diagnostics Companies Headquarters
Table 16. Date of International Companies Enter into In-Vitro Diagnostics Market
Table 17. Global In-Vitro Diagnostics Companies Product & Service
Table 18. Global In-Vitro Diagnostics Mergers & Acquisitions, Expansion Plans
Table 19. Roche Corporation Information
Table 20. Roche Description and Business Overview
Table 21. Roche In-Vitro Diagnostics Product
Table 22. Roche In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Roche Revenue Proportion of In-Vitro Diagnostics by Product in 2024
Table 24. Roche Revenue Proportion of In-Vitro Diagnostics by Application in 2024
Table 25. Roche Revenue Proportion of In-Vitro Diagnostics by Geographic Area in 2024
Table 26. Roche Recent Developments
Table 27. Siemens Corporation Information
Table 28. Siemens Description and Business Overview
Table 29. Siemens In-Vitro Diagnostics Product
Table 30. Siemens In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Siemens Revenue Proportion of In-Vitro Diagnostics by Product in 2024
Table 32. Siemens Revenue Proportion of In-Vitro Diagnostics by Application in 2024
Table 33. Siemens Revenue Proportion of In-Vitro Diagnostics by Geographic Area in 2024
Table 34. Siemens Recent Developments
Table 35. Abbott Corporation Information
Table 36. Abbott Description and Business Overview
Table 37. Abbott In-Vitro Diagnostics Product
Table 38. Abbott In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Abbott Revenue Proportion of In-Vitro Diagnostics by Product in 2024
Table 40. Abbott Revenue Proportion of In-Vitro Diagnostics by Application in 2024
Table 41. Abbott Revenue Proportion of In-Vitro Diagnostics by Geographic Area in 2024
Table 42. Abbott Recent Developments
Table 43. Danaher Corporation Information
Table 44. Danaher Description and Business Overview
Table 45. Danaher In-Vitro Diagnostics Product
Table 46. Danaher In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Danaher Revenue Proportion of In-Vitro Diagnostics by Product in 2024
Table 48. Danaher Revenue Proportion of In-Vitro Diagnostics by Application in 2024
Table 49. Danaher Revenue Proportion of In-Vitro Diagnostics by Geographic Area in 2024
Table 50. Danaher Recent Developments
Table 51. Thermo Fisher Corporation Information
Table 52. Thermo Fisher Description and Business Overview
Table 53. Thermo Fisher In-Vitro Diagnostics Product
Table 54. Thermo Fisher In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Thermo Fisher Revenue Proportion of In-Vitro Diagnostics by Product in 2024
Table 56. Thermo Fisher Revenue Proportion of In-Vitro Diagnostics by Application in 2024
Table 57. Thermo Fisher Revenue Proportion of In-Vitro Diagnostics by Geographic Area in 2024
Table 58. Thermo Fisher Recent Developments
Table 59. BioMerieux Corporation Information
Table 60. BioMerieux Description and Business Overview
Table 61. BioMerieux In-Vitro Diagnostics Product
Table 62. BioMerieux In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. BioMerieux Revenue Proportion of In-Vitro Diagnostics by Product in 2024
Table 64. BioMerieux Revenue Proportion of In-Vitro Diagnostics by Application in 2024
Table 65. BioMerieux Revenue Proportion of In-Vitro Diagnostics by Geographic Area in 2024
Table 66. BioMerieux Recent Developments
Table 67. Bio-Rad Corporation Information
Table 68. Bio-Rad Description and Business Overview
Table 69. Bio-Rad In-Vitro Diagnostics Product
Table 70. Bio-Rad In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Bio-Rad Revenue Proportion of In-Vitro Diagnostics by Product in 2024
Table 72. Bio-Rad Revenue Proportion of In-Vitro Diagnostics by Application in 2024
Table 73. Bio-Rad Revenue Proportion of In-Vitro Diagnostics by Geographic Area in 2024
Table 74. Bio-Rad Recent Developments
Table 75. BD Corporation Information
Table 76. BD Description and Business Overview
Table 77. BD In-Vitro Diagnostics Product
Table 78. BD In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. BD Revenue Proportion of In-Vitro Diagnostics by Product in 2024
Table 80. BD Revenue Proportion of In-Vitro Diagnostics by Application in 2024
Table 81. BD Revenue Proportion of In-Vitro Diagnostics by Geographic Area in 2024
Table 82. BD Recent Developments
Table 83. JNJ Corporation Information
Table 84. JNJ Description and Business Overview
Table 85. JNJ In-Vitro Diagnostics Product
Table 86. JNJ In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. JNJ Revenue Proportion of In-Vitro Diagnostics by Product in 2024
Table 88. JNJ Revenue Proportion of In-Vitro Diagnostics by Application in 2024
Table 89. JNJ Revenue Proportion of In-Vitro Diagnostics by Geographic Area in 2024
Table 90. JNJ Recent Developments
Table 91. Sysmex Corporation Information
Table 92. Sysmex Description and Business Overview
Table 93. Sysmex In-Vitro Diagnostics Product
Table 94. Sysmex In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Sysmex Revenue Proportion of In-Vitro Diagnostics by Product in 2024
Table 96. Sysmex Revenue Proportion of In-Vitro Diagnostics by Application in 2024
Table 97. Sysmex Revenue Proportion of In-Vitro Diagnostics by Geographic Area in 2024
Table 98. Sysmex Recent Developments
Table 99. KHB Corporation Information
Table 100. KHB Description and Business Overview
Table 101. KHB In-Vitro Diagnostics Product
Table 102. KHB In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. KHB Revenue Proportion of In-Vitro Diagnostics by Product in 2024
Table 104. KHB Revenue Proportion of In-Vitro Diagnostics by Application in 2024
Table 105. KHB Revenue Proportion of In-Vitro Diagnostics by Geographic Area in 2024
Table 106. KHB Recent Developments
Table 107. DaAn Gene Corporation Information
Table 108. DaAn Gene Description and Business Overview
Table 109. DaAn Gene In-Vitro Diagnostics Product
Table 110. DaAn Gene In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. DaAn Gene Revenue Proportion of In-Vitro Diagnostics by Product in 2024
Table 112. DaAn Gene Revenue Proportion of In-Vitro Diagnostics by Application in 2024
Table 113. DaAn Gene Revenue Proportion of In-Vitro Diagnostics by Geographic Area in 2024
Table 114. DaAn Gene Recent Developments
Table 115. Leadman Corporation Information
Table 116. Leadman Description and Business Overview
Table 117. Leadman In-Vitro Diagnostics Product
Table 118. Leadman In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Leadman Revenue Proportion of In-Vitro Diagnostics by Product in 2024
Table 120. Leadman Revenue Proportion of In-Vitro Diagnostics by Application in 2024
Table 121. Leadman Revenue Proportion of In-Vitro Diagnostics by Geographic Area in 2024
Table 122. Leadman Recent Developments
Table 123. BioSino Corporation Information
Table 124. BioSino Description and Business Overview
Table 125. BioSino In-Vitro Diagnostics Product
Table 126. BioSino In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. BioSino Revenue Proportion of In-Vitro Diagnostics by Product in 2024
Table 128. BioSino Revenue Proportion of In-Vitro Diagnostics by Application in 2024
Table 129. BioSino Revenue Proportion of In-Vitro Diagnostics by Geographic Area in 2024
Table 130. BioSino Recent Developments
Table 131. BSBE Corporation Information
Table 132. BSBE Description and Business Overview
Table 133. BSBE In-Vitro Diagnostics Product
Table 134. BSBE In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. BSBE Revenue Proportion of In-Vitro Diagnostics by Product in 2024
Table 136. BSBE Revenue Proportion of In-Vitro Diagnostics by Application in 2024
Table 137. BSBE Revenue Proportion of In-Vitro Diagnostics by Geographic Area in 2024
Table 138. BSBE Recent Developments
Table 139. Maccura Corporation Information
Table 140. Maccura Description and Business Overview
Table 141. Maccura In-Vitro Diagnostics Product
Table 142. Maccura In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Maccura Revenue Proportion of In-Vitro Diagnostics by Product in 2024
Table 144. Maccura Revenue Proportion of In-Vitro Diagnostics by Application in 2024
Table 145. Maccura Revenue Proportion of In-Vitro Diagnostics by Geographic Area in 2024
Table 146. Maccura Recent Developments
Table 147. North America In-Vitro Diagnostics Revenue by Country (2020-2025) & (US$ Million)
Table 148. North America In-Vitro Diagnostics Revenue by Country (2026-2031) & (US$ Million)
Table 149. North America In-Vitro Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 150. North America In-Vitro Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 151. Asia-Pacific In-Vitro Diagnostics Revenue by Region (2020-2025) & (US$ Million)
Table 152. Asia-Pacific In-Vitro Diagnostics Revenue by Region (2026-2031) & (US$ Million)
Table 153. Asia-Pacific In-Vitro Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 154. Asia-Pacific In-Vitro Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 155. Europe In-Vitro Diagnostics Revenue by Country (2020-2025) & (US$ Million)
Table 156. Europe In-Vitro Diagnostics Revenue by Country (2026-2031) & (US$ Million)
Table 157. Europe In-Vitro Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 158. Europe In-Vitro Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 159. Latin America In-Vitro Diagnostics Revenue by Country (2020-2025) & (US$ Million)
Table 160. Latin America In-Vitro Diagnostics Revenue by Country (2026-2031) & (US$ Million)
Table 161. Latin America In-Vitro Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 162. Latin America In-Vitro Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 163. Middle East and Africa In-Vitro Diagnostics Revenue by Country (2020-2025) & (US$ Million)
Table 164. Middle East and Africa In-Vitro Diagnostics Revenue by Country (2026-2031) & (US$ Million)
Table 165. Middle East and Africa In-Vitro Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 166. Middle East and Africa In-Vitro Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 167. In-Vitro Diagnostics Key Raw Materials, Industry Status and Trend
Table 168. In-Vitro Diagnostics Key Raw Materials and Upstream Suppliers
Table 169. In-Vitro Diagnostics Clients Status and Trend
Table 170. In-Vitro Diagnostics Typical Clients
Table 171. In-Vitro Diagnostics Distributors
Table 172. In-Vitro Diagnostics Market Trends
Table 173. In-Vitro Diagnostics Market Drivers
Table 174. In-Vitro Diagnostics Market Challenges
Table 175. In-Vitro Diagnostics Market Restraints
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. In-Vitro Diagnostics Product Picture
Figure 2. Global In-Vitro Diagnostics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global In-Vitro Diagnostics Revenue Market Share by Type in 2024 & 2031
Figure 4. Tissue Diagnostics Product Picture
Figure 5. Professional Diagnostic Product Picture
Figure 6. Molecular Diagnostic Product Picture
Figure 7. Diabetes Monitoring Product Picture
Figure 8. Other Product Picture
Figure 9. Global In-Vitro Diagnostics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 10. Global In-Vitro Diagnostics Revenue Market Share by Application in 2024 & 2031
Figure 11. Diabetes
Figure 12. Infectious Diseases
Figure 13. Oncology
Figure 14. Cardiology
Figure 15. HIV
Figure 16. Other
Figure 17. In-Vitro Diagnostics Report Years Considered
Figure 18. Global In-Vitro Diagnostics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global In-Vitro Diagnostics Market Size (2020-2031) & (US$ Million)
Figure 20. Global In-Vitro Diagnostics Market Size Market Share by Region: 2024 Versus 2031
Figure 21. Global In-Vitro Diagnostics Revenue Market Share by Region (2020-2031)
Figure 22. Global In-Vitro Diagnostics Revenue Market Share Forecast by Type (2020-2031)
Figure 23. Global In-Vitro Diagnostics Revenue Market Share Forecast by Application (2020-2031)
Figure 24. Tissue Diagnostics of In-Vitro Diagnostics Revenue Market Share by Application, 2024 VS 2031
Figure 25. Professional Diagnostic of In-Vitro Diagnostics Revenue Market Share by Application, 2024 VS 2031
Figure 26. Molecular Diagnostic of In-Vitro Diagnostics Revenue Market Share by Application, 2024 VS 2031
Figure 27. Diabetes Monitoring of In-Vitro Diagnostics Revenue Market Share by Application, 2024 VS 2031
Figure 28. Other of In-Vitro Diagnostics Revenue Market Share by Application, 2024 VS 2031
Figure 29. In-Vitro Diagnostics Revenue Share by Company (2024)
Figure 30. In-Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 31. Tissue Diagnostics Revenue Proportion by Company in 2024
Figure 32. Professional Diagnostic Revenue Proportion by Company in 2024
Figure 33. Molecular Diagnostic Revenue Proportion by Company in 2024
Figure 34. Diabetes Monitoring Revenue Proportion by Company in 2024
Figure 35. Other Revenue Proportion by Company in 2024
Figure 36. North America In-Vitro Diagnostics Revenue 2020-2031 (US$ Million)
Figure 37. North America In-Vitro Diagnostics Revenue Market Share by Type (2020-2025)
Figure 38. North America In-Vitro Diagnostics Revenue Market Share by Application (2020-2025)
Figure 39. Asia-Pacific In-Vitro Diagnostics Revenue 2020-2031 (US$ Million)
Figure 40. Asia-Pacific In-Vitro Diagnostics Revenue Market Share by Region (2020-2031)
Figure 41. Asia-Pacific In-Vitro Diagnostics Revenue Market Share by Type (2020-2025)
Figure 42. Asia-Pacific In-Vitro Diagnostics Revenue Market Share by Application (2020-2025)
Figure 43. Europe In-Vitro Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Europe In-Vitro Diagnostics Revenue Market Share by Country (2020-2031)
Figure 45. Europe In-Vitro Diagnostics Revenue Market Share by Type (2020-2025)
Figure 46. Europe In-Vitro Diagnostics Revenue Market Share by Application (2020-2025)
Figure 47. Latin America In-Vitro Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Latin America In-Vitro Diagnostics Revenue Market Share by Country (2020-2031)
Figure 49. Latin America In-Vitro Diagnostics Revenue Market Share by Type (2020-2025)
Figure 50. Latin America In-Vitro Diagnostics Revenue Market Share by Application (2020-2025)
Figure 51. Middle East and Africa In-Vitro Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 52. Middle East and Africa In-Vitro Diagnostics Revenue Market Share by Country (2020-2031)
Figure 53. Middle East and Africa In-Vitro Diagnostics Revenue Market Share by Type (2020-2025)
Figure 54. Middle East and Africa In-Vitro Diagnostics Revenue Market Share by Application (2020-2025)
Figure 55. In-Vitro Diagnostics Supply Chain (Upstream and Downstream Market)
Figure 56. Global Production Market Share of In-Vitro Diagnostics Raw Materials by Region in 2024
Figure 57. In-Vitro Diagnostics Distribution Channels
Figure 58. Global In-Vitro Diagnostics Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 59. Global In-Vitro Diagnostics Percentage 2020-2031: Online Sales VS Offline Sales
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
